Skip to content

Intraocular Pressure Changes Associated With Tracheal Extubation: Comparison of Sugammadex With Conventional Reversal of Neuromuscular Blockade

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02215382
Enrollment
36
Registered
2014-08-13
Start date
2014-08-31
Completion date
2014-11-30
Last updated
2015-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular Pressure Changes During Tracheal Extubation

Keywords

two reversal methods, changes in IOP, heart rate, blood pressure, tracheal extubation

Brief summary

The aim of this study, comparison of effects of sugammadex versus neostigmine/atropine combination on hemodynamic parameters and intraocular pressure during tracheal extubation. This prospective, randomised study was designed to compare two reversal methods with respect to changes in IOP, heart rate and blood pressure during tracheal extubation period.

Interventions

DRUGsugammadex

sugammadex 2 mg/kg

neostigmine 0,05 mg/kg + atropine 0,025 mg/kg

Sponsors

Ordu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II physical status * elective surgery * endotracheal intubation under general anesthesia

Exclusion criteria

* emergency surgery * pregnancy * laparoscopic surgery * prone position * BMI \> 30 kg/m2 * sedative drug use in last month * patients with glaucoma. * ASA \> II physical status

Design outcomes

Primary

MeasureTime frame
intraocular pressurebaseline, before applying reversal agent, after applying reversal agent, one, three, five and ten minutes after tracheal extubation

Secondary

MeasureTime frame
heart ratebaseline, before applying reversal agent, after applying reversal agent, one, three, five and ten minutes after tracheal extubation
blood pressurebaseline, before applying reversal agent, after applying reversal agent, one, three, five and ten minutes after tracheal extubation

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026